BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

27 related articles for article (PubMed ID: 3677069)

  • 1. Mechanism of Action of KL-50, a Candidate Imidazotetrazine for the Treatment of Drug-Resistant Brain Cancers.
    Huseman ED; Lo A; Fedorova O; Elia JL; Gueble SE; Lin K; Sundaram RK; Oh J; Liu J; Menges F; Rees MG; Ronan MM; Roth JA; Batista VS; Crawford JM; Pyle AM; Bindra RS; Herzon SB
    J Am Chem Soc; 2024 May; ():. PubMed ID: 38815248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Covalent capture of a human O(6)-alkylguanine alkyltransferase-DNA complex using N(1),O(6)-ethanoxanthosine, a mechanism-based crosslinker.
    Noll DM; Clarke ND
    Nucleic Acids Res; 2001 Oct; 29(19):4025-34. PubMed ID: 11574685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formation of covalent complexes between human O6-alkylguanine-DNA alkyltransferase and BCNU-treated defined length synthetic oligodeoxynucleotides.
    Brent TP; Remack JS
    Nucleic Acids Res; 1988 Jul; 16(14B):6779-88. PubMed ID: 3405749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemosensitivity testing of human gliomas using a fluorescent microcarrier technique.
    Bowles AP; Pantazis CG; Wansley W; Allen MB
    J Neurooncol; 1990 Apr; 8(2):103-12. PubMed ID: 2358844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that covalent complex formation between BCNU-treated oligonucleotides and E. coli alkyltransferases requires the O6-alkylguanine function.
    Gonzaga PE; Harris L; Margison GP; Brent TP
    Nucleic Acids Res; 1990 Jul; 18(13):3961-6. PubMed ID: 2197601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Properties and assay of mammalian O6-alkylguanine-DNA alkyltransferase.
    Pegg AE; Dolan ME
    Pharmacol Ther; 1987; 34(2):167-79. PubMed ID: 3317450
    [No Abstract]   [Full Text] [Related]  

  • 7. Evidence that O6-alkylguanine-DNA alkyltransferase becomes covalently bound to DNA containing 1,3-bis(2-chloroethyl)-1-nitrosourea-induced precursors of interstrand cross-links.
    Brent TP; Smith DG; Remack JS
    Biochem Biophys Res Commun; 1987 Jan; 142(2):341-7. PubMed ID: 3814140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation of DNA interstrand cross-links by the novel chloroethylating agent 2-chloroethyl(methylsulfonyl)methanesulfonate: suppression by O6-alkylguanine-DNA alkyltransferase purified from human leukemic lymphoblasts.
    Brent TP; Lestrud SO; Smith DG; Remack JS
    Cancer Res; 1987 Jul; 47(13):3384-7. PubMed ID: 3034412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of 1-(3-deoxycytidyl),2-(1-deoxyguanosinyl)ethane cross-link formation in DNA by rat liver O6-alkylguanine-DNA alkyltransferase.
    Ludlum DB; Mehta JR; Tong WP
    Cancer Res; 1986 Jul; 46(7):3353-7. PubMed ID: 3708569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of O6-methylguanine on DNA interstrand cross-link formation by chloroethylnitrosoureas and 2-chloroethyl(methylsulfonyl)methanesulfonate.
    Dolan ME; Pegg AE; Hora NK; Erickson LC
    Cancer Res; 1988 Jul; 48(13):3603-6. PubMed ID: 2837318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response of cultured human cell lines from rhabdomyosarcoma xenografts to treatment with chloroethylnitrosoureas.
    Smith DG; Brent TP
    Cancer Res; 1989 Feb; 49(4):883-6. PubMed ID: 2521455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a novel reaction by human O6-alkylguanine-DNA alkyltransferase with 1,3-bis(2-chloroethyl)-1-nitrosourea-treated DNA.
    Brent TP; Remack JS; Smith DG
    Cancer Res; 1987 Dec; 47(23):6185-8. PubMed ID: 3677069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and purification of O6-alkylguanine-DNA alkyltransferase from human leukemic cells. Prevention of chloroethylnitrosourea-induced cross-links by purified enzyme.
    Brent TP
    Pharmacol Ther; 1985; 31(1-2):121-40. PubMed ID: 3916338
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.